Calliditas Therapeutics: Calliditas CEO acquires shares through the exercise of Calliditas' warrant program 2018/2022
STOCKHOLM, March 24, 2022 /PRNewswire/ -- Calliditas Therapeutics AB (publ) (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced today that CEO Renée Aguiar-Lucander has subscribed
Source: finanznachrichten.de